The clinical impact of late gadolinium enhancement in Takotsubo cardiomyopathy: serial analysis of cardiovascular magnetic resonance images
© Naruse et al; licensee BioMed Central Ltd. 2011
Received: 5 June 2011
Accepted: 29 October 2011
Published: 29 October 2011
Our study aimed to investigate both the clinical implications of late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) and the relation of LGE to clinical findings in patients with Takotsubo cardiomyopathy (TTC).
We evaluated 20 consecutive patients (2 men, 18 women; median age, 77 years; interquartile range [IQR] 67-82 years) who were admitted to our hospital with the diagnosis of TTC. CMR was performed within 1 week after admission, and follow-up studies were conducted 1.5 and 6 months later.
In 8 patients, CMR imaging during the sub-acute phase revealed LGE in the area matched with wall motion impairment. Cardiogenic shock was more frequently observed in patients with LGE than in those without LGE (38% vs 0%, p = 0.049). The patients with LGE needed a longer duration for ECG normalization and recovery of wall motion than did those without LGE (median 205 days, IQR [152-363] vs 68 days, [43-145], p = 0.005; 15 days, [10-185] vs 7 days, [4-13], p = 0.030, respectively). In 5 of these 8 patients, LGE disappeared within 45-180 days (170, IQR [56-180]) of onset. The patients with LGE remaining in the chronic phase had higher peak creatine kinase levels than did those without LGE (median 307 IU/L, IQR [264-460] vs 202 IU/L, [120-218], p = 0.017).
LGE by CMR in the sub-acute phase may be associated with the severity and prolonged recovery to normal of clinical findings in TTC.
KeywordsTakotsubo cardiomyopathy Cardiac magnetic resonance Cardiac dysfunction
Takotsubo cardiomyopathy (TTC), also referred to as transient left ventricular apical ballooning or stress cardiomyopathy, was first reported by Sato et al.  in 1990. Several studies have recently reported the clinical experience and profiles of this syndrome from Japan and other parts of the world [2–8]. These patients showed a reversible balloon-like left ventricular apical wall motion abnormality that returned to normal within several weeks and had chest symptoms, ST elevation, and minimal elevation of cardiac enzyme levels mimicking acute myocardial infarction without significant luminal narrowing of the coronary arteries. There was a high predominance in elderly women, and several instances were possibly triggered by physical or emotional stress. However, the pathophysiological mechanism of TTC has not yet been fully clarified.
Late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) can reveal small and focal myocardial abnormalities and can be useful to diagnose various cardiac diseases . It remains controversial whether LGE is present and which type of LGE is observed in patients with TTC. Initially, some studies showed that the absence of irreversible myocardial damage, as indicated by no LGE, is one of the predominant features of TTC, and CMR may be helpful in excluding myocardial infarction because LGE is not a feature of TTC [8, 10–12]. However, histological analysis of the heart in TCC shows sparse foci of myocardial necrosis with contraction bands in the akinetic area [8, 13–15], and recently, several studies reported LGE in patients with TTC [7, 16–20]. Rolf et al.  showed evidence for the immunohistological basis of the LGE phenomenon in patients with TTC. Furthermore, Eitel et al.  found that LGE by CMR showed minute focal or patchy nonischemic myocardial scarring in 9% of patient with TTC. However, the time course of LGE by CMR and the relation between LGE and other clinical findings in TTC remain unclear. Therefore, we assessed by serial analysis both the clinical implications of LGE and the relation of LGE to clinical findings in patients with TTC.
Study protocol and study subjects
This study was prospectively conducted between April 2006 and November 2009 at Seirei Mikatahara Hospital, Hamamatsu, Japan. The protocol was approved by the local institutional review board, and all patients gave their written informed consent after the nature of the study and procedures had been fully explained. We prospectively enrolled 20 consecutive patients (2 men and 18 women; median age, 77 years; range 45-88 years; interquartile range (IQR) 67-82 years) who were admitted to our hospital with the diagnosis of TTC according to the criteria of the Mayo Clinic . Patients were included if they had no contraindication to CMR (pacemaker, intracranial metal, claustrophobia, or obesity [> 150 kg body weight]). Coronary angiography and left ventriculography were performed within 24 hours of presentation in all patients. All patients underwent electrocardiography and transthoracic echocardiography on admission day, 3 times per week during their hospital stay, and at each outpatient clinic visit. CMR was performed within 1 week of admission, and follow-up imaging studies were conducted at 1.5 and 6 months after admission or until the findings improved. No patient was excluded for technical or image quality reasons. During follow-up, 1 patient died from a non-cardiac cause, and the remaining patients all underwent follow-up study.
Protocol for CMR imaging
MR images were acquired with the patient in the supine position with a 1.5-T whole-body MR system (Magnetom Vision; Siemens Medical Systems, Erlangen, Germany) with a four-element phased-array cardiac coil for signal reception. The CMR images were gated to the electrocardiographic signal and were obtained during repeated breath-holds. Cine CMR images encompassing the entire left ventricular cycle were acquired on contiguous short-axis imaging planes with a segmented, fast, low-angle shot cine sequence. The CMR parameters included a repetition time of 4.2 milliseconds for each cine frame, echo time of 1.9 milliseconds, flip angle of 45°, reduction factor of 2, bandwidth of 125 kHz, section thickness of 8 mm with a 2-mm gap, field of view of 240 × 320 mm, and a 320 × 200 image matrix. Fifteen minutes after injection of a gadolinium diethylenetriamine pentaacetic acid contrast agent (Magnevist, Schering AG, Berlin, Germany; 0.1 mmol/kg), LGE inversion recovery images were acquired in the same orientation as the cine images using a 2-dimensional inversion-recovery gradient echo pulse sequence. The following imaging parameters were used: repetition time, 6.6 milliseconds; echo time, 3.1 milliseconds; flip angle, 25°; inversion time, 180 to 230 milliseconds; bandwidth, 31.25 kHz; trigger delay time for inversion recovery pulse, 200 milliseconds; section thickness, 10 mm; field of view, 240 × 320 mm; and image matrix, 192 × 256. The scan parameters were the same for all serial CMR.
CMR image analysis
Images were analyzed according to the consensus of two observers who were blinded to patient data and the results of all other examinations. On all short-axis cine slices, the endocardial and epicardial borders were outlined manually on left ventricular end-diastolic and end-systolic images, excluding trabeculae and papillary muscles. The left ventricular ejection fraction was calculated as follows: (end-diastolic volume - end-systolic volume)/end-diastolic volume. For analysis of the LGE inversion recovery images, LGE was defined as an area of high signal intensity that was 2 and 5 standard deviations (SD) or more greater than the signal intensity of nonenhanced myocardium [22, 24]. If differentiation between hyperenhanced subendocardium and the blood pool proved difficult, the subendocardial edge of the corresponding cine image was used as a reference. After determining the total volume of enhanced tissue, the percentage of LGE tissue volume for total left ventricular myocardium (LGE area ratio) was calculated as follows: (volume of enhanced tissue × 100/total volume of left ventricular myocardium) (%).
Continuous variables are expressed as range, median, and IQR. Because of the limited sample size, non-parametric Mann-Whitney U tests were used to test for statistically significant differences in continuous variables between the study groups. Serial LGE-CMR images were compared using Wilcoxon's signed rank test for paired variables. Categorical variables were compared by Fisher's exact tests. Spearman coefficients were used to evaluate correlation between the LGE area ratio and the duration of abnormal electrocardiographic changes or echocardiographic akinesis. All probability values were 2-sided, and a value of P < 0.05 was considered statistically significant. All analyses were performed with the SPSS 15.0 software package (SPSS, Chicago, IL, USA).
Clinical characteristics of the patients with Takotsubo cardiomyopathy
Female sex, n (%)
Triggering factor (emotional/physical)
Peak creatine kinase level (IU/L)
Serum noradrenaline elevation
Ejection fraction (LVG) (%)
Time from symptom onset to CMR (days)
Ejection fraction (CMR) (%)
Duration to normalization (days)
The initial electrocardiogram showed ST-segment elevation of at least 1 mm in 12 patients. Pathologic Q waves were not seen in any patient. ECG abnormalities returned to normal within 45-468 days (151, IQR 130-193 days) after onset.
Echocardiography during the acute phase revealed akinesia of the mid and/or apical portion of the left ventricle compared with hypercontraction of the basal left ventricle. Left ventricular outflow tract obstruction occurred in 1 patient. Resolution of the initial echocardiographic abnormalities was observed in all patients within 3-37 days (11, IQR 6-15 days) after onset.
CMR in the sub-acute phase was performed at 2-7 days (5, IQR 3-6 days) after onset. The left ventricular ejection fraction at this time was 41-69% (51, IQR 45-54%). Complete resolution of wall motion abnormalities had occurred in 3 patients (2 patients with typical TTC and 1 patient with the atypical form). In the remaining 16 patients, wall motion abnormalities had improved but were still demonstrable.
In the sub-acute phase, the LGE and non-LGE subgroups did not differ significantly in age, sex, triggering factor, chest pain, congestive heart failure, peak creatine kinase, noradrenaline elevation, ECG abnormalities, left ventricular outflow tract obstruction, ejection fraction, type of TTC, and time from onset of symptoms to CMR. The LGE group had a greater prevalence of cardiogenic shock than did the non-LGE group. The LGE group in the sub-acute phase required longer time to normalize ECG and echocardiographic changes than did the non-LGE group (Table 1).
The 3 patients with LGE remaining in the chronic phase had higher peak creatine kinase levels than did the non-LGE patients in the chronic phase (307 IU/L, IQR 264-460 IU/L vs 202 IU/L, IQR 120-218 IU/L, p = 0.017).
The major findings of this study are as follows: (1) in 8 of 20 patients with TTC, CMR showed LGE in the matched area of wall motion impairment during the sub-acute phase; (2) cardiogenic shock was more frequently observed in the patients with LGE than in those without LGE; (3) the patients with LGE had a longer duration to ECG normalization and recovery of wall motion than did those without LGE; (4) in 5 of the 8 patients, LGE disappeared within 45-180 days (170, IQR 56-180 days) from onset of TTC; and (5) patients with LGE remaining in the chronic phase had higher peak creatine kinase levels than did patients without LGE in the chronic phase.
CMR findings of TTC
In the present study, we showed that LGE can be present in some cases of TTC. However, the signal intensity found was lower than that usually documented in cases of myocardial infarction or myocarditis. There have been several reports of LGE in TTC so far [16–22]. Because CMR is shown to be able to detect a small and focal myocardial abnormality, LGE could reflect contraction-band necrosis. Yoshida et al.  reported that 3 of 9 patients had mononuclear inflammatory infiltrates, and 4 patients had contraction-band necrosis. Wittstein et al.  showed that 1 of 5 patients had an extensive inflammatory lymphocytic infiltrate and multiple foci of contraction-band necrosis. Both Sacha et al.  and Maréchaux et al.  reported cases of contraction-band necrosis detected at autopsy. In our study, the patients with LGE remaining in the chronic phase had higher peak creatine kinase levels than did the patients without LGE in the chronic phase. We therefore consider that contraction-band necrosis might be one cause of LGE in the patients with TTC. Our results provide evidence that the presence of LGE cannot rule out TTC.
Rolf et al.  found a significantly higher increase of extracellular matrix as represented by collagen-1 staining in 5 of 15 patients with LGE, which was defined as an area of high signal intensity that was 2 SD or more greater than the signal intensity of nonenhanced myocardium. Because the varying degrees of fibrosis found in several biopsies suggested the presence of islands of fibrosis in the left ventricle, this may explain the patchy character of LGE .
Eitel et al.  showed that focal and patchy LGE was detected in 22 of 239 patients when using a threshold of 3 SD instead of 5 SD above the mean of remote myocardium to define significant enhancement; however, none of their patients had evidence of LGE when using a threshold of 5 SD, which represents the cutoff for fibrosis detection in acute myocardial infarction and myocarditis. The definition of LGE in our study used the threshold of 2 SD and that may be responsible for the finding that the prevalence of LGE-positive patients was higher in our study than that in the Eitel et al.  study. In fact, when a threshold of 5 SD was applied to our study population, no patient had LGE in either the sub-acute phase or the chronic phase. We consider that no LGE as defined by a high threshold of 5 SD is one feature of the patients with TTC; however, we believe that evaluation of the presence of LGE using a low threshold of 2 SD might also have some clinical value, as discussed above.
Possible speculations are that severe stress-induced stunning of the apical segments leads to a patchy pattern of myocardial contraction-band necrosis possibly accompanied by a certain amount of transient focal/patchy edema or deposition of extracellular matrix resulting in LGE with low signal intensity. LGE remains in the chronic phase if the amount of contraction-band necrosis is above voxel resolution. Otherwise, LGE in the chronic phase completely normalizes if contraction-band necrosis is not present or is less than voxel resolution.
Our study showed that TTC in the sub-acute phase can have LGE with lower signal intensity than that usually documented in cases of myocardial infarction or myocarditis. For differentiation of TTC from similar symptoms of the acute coronary event, CMR can also help to define the relation of the myocardial segments with wall motion abnormality and the supplied epicardial territory. This implies that if specific CMR characteristics prove to be a non-invasive diagnostic sign for TTC, this could potentially obviate the need for an invasive diagnostic procedure.
We could also show that the patients with LGE experienced cardiogenic shock more frequently and had a longer duration to ECG normalization and recovery of wall motion than did those without LGE. These results suggest that the existence and extent of LGE in the sub-acute phase may be associated with the severity and prolonged recovery of clinical findings in TTC.
This study is limited by its small sample size; thus, further studies will be needed to confirm our findings. Because we did not perform endomyocardial biopsy in this study, we cannot confirm the relation between histological findings and findings of LGE by CMR in the same patient. Although several studies with CMR have shown the presence of myocardial edema observed on T2-weighted imaging , T2 sequences were not acquired in our study.
In conclusion, the LGE and gradual decrease in the LGE tissue volume seen in TTC are much different from the CMR findings in myocardial infarction and other cardiomyopathies and may reflect discrete myocardial contraction-band necrosis and transient focal/patchy edema or deposition of extracellular matrix. The presence of LGE cannot rule out TTC. LGE by CMR imaging in the sub-acute phase may be associated with the severity and prolonged recovery to normal of clinical findings in TTC.
List of abbreviations used
cardiovascular magnetic resonance
late gadolinium enhancement
The authors are grateful to Takahiro Natsume for his valuable technical assistance and to Norihito Saitoh for his excellent strategic advice and encouragement.
- Sato H, Tateishi H, Uchida T: Takotsubo-type cardiomyopathy due to multivessel spasm. Clinical Aspects of Myocardial Injury: From Ischemia to Heart Failure. Edited by: Kodama K, Haze K, Hon M. 1990, Tokyo: Kagakuhyouronsha Publishing, 56-64. [in Japanese]Google Scholar
- Tsuchihashi K, Ueshima K, Uchida T, Oh-mura N, Kimura K, Owa M, Yoshiyama M, Miyazaki S, Haze K, Ogawa H, Honda T, Hase M, Kai R, Morii I, Angina Pectoris-Myocardial Infarction Investigations in Japan: Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction. Angina Pectoris-Myocardial Infarction Investigations in Japan. J Am Coll Cardiol. 2001, 38: 11-18. 10.1016/S0735-1097(01)01316-X.View ArticlePubMedGoogle Scholar
- Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H: Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol. 2003, 41: 737-742. 10.1016/S0735-1097(02)02925-X.View ArticlePubMedGoogle Scholar
- Sato A, Aonuma K, Nozato T, Sekiguchi Y, Okazaki O, Kubota K, Hiroe M: Stunned myocardium in transient left ventricular apical ballooning: a serial study of dual I-123 BMIPP and Tl-201 SPECT. J Nucl Cardiol. 2008, 15: 671-679. 10.1016/j.nuclcard.2008.03.010.View ArticlePubMedGoogle Scholar
- Desmet WJ, Adriaenssens BF, Dens JA: Apical ballooning of the left ventricle: first series in white patients. Heart. 2003, 89: 1027-1031. 10.1136/heart.89.9.1027.PubMed CentralView ArticlePubMedGoogle Scholar
- Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG, Wright RS, Rihal CS: Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol. 2004, 94: 343-346. 10.1016/j.amjcard.2004.04.030.View ArticlePubMedGoogle Scholar
- Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, Maron BJ: Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation. 2005, 111: 472-479. 10.1161/01.CIR.0000153801.51470.EB.View ArticlePubMedGoogle Scholar
- Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC, Rade JJ, Bivalacqua TJ, Champion HC: Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005, 352: 539-548. 10.1056/NEJMoa043046.View ArticlePubMedGoogle Scholar
- Kim DH, Choi SI, Chang HJ, Choi DJ, Lim C, Park JH: Delayed hyperenhancement by contrast-enhanced magnetic resonance imaging: Clinical application for various cardiac diseases. J Comput Assist Tomogr. 2006, 30: 226-232. 10.1097/00004728-200603000-00011.View ArticlePubMedGoogle Scholar
- Gerbaud E, Montaudon M, Leroux L, Corneloup O, Dos Santos P, Jaïs C, Coste P, Laurent F: MRI for the diagnosis of left ventricular apical ballooning syndrome (LVABS). Eur Radiol. 2008, 18: 947-954. 10.1007/s00330-008-0853-9.View ArticlePubMedGoogle Scholar
- Mitchell JH, Hadden TB, Wilson JM, Achari A, Muthupillai R, Flamm SD: Clinical features and usefulness of cardiac magnetic resonance imaging in assessing myocardial viability and prognosis in Takotsubo cardiomyopathy (transient left ventricular apical ballooning syndrome). Am J Cardiol. 2007, 100: 296-301. 10.1016/j.amjcard.2007.02.091.View ArticlePubMedGoogle Scholar
- Nef HM, Möllmann H, Kostin S, Troidl C, Voss S, Weber M, Dill T, Rolf A, Brandt R, Hamm CW, Elsässer A: Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J. 2007, 28: 2456-2464. 10.1093/eurheartj/ehl570.View ArticlePubMedGoogle Scholar
- Yoshida T, Hibino T, Kako N, Murai S, Oguri M, Kato K, Yajima K, Ohte N, Yokoi K, Kimura G: A pathophysiologic study of tako-tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography. Eur Heart J. 2007, 28: 2598-2604. 10.1093/eurheartj/ehm401.View ArticlePubMedGoogle Scholar
- Sacha J, Maselko J, Wester A, Szudrowicz Z, Pluta W: Left ventricular apical rupture caused by takotsubo cardiomyopathy--comprehensive pathological heart investigation. Circ J. 2007, 71: 982-985. 10.1253/circj.71.982.View ArticlePubMedGoogle Scholar
- Maréchaux S, Fornes P, Petit S, Poisson C, Thevenin D, Le Tourneau T, Asseman P, Bruneval P, Ennezat PV: Pathology of inverted Takotsubo cardiomyopathy. Cardiovasc Pathol. 2008, 17: 241-243. 10.1016/j.carpath.2007.08.002.View ArticlePubMedGoogle Scholar
- Abdel-Aty H, Cocker M, Friedrich MG: Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol. 2009, 132: 291-293. 10.1016/j.ijcard.2007.08.102.View ArticlePubMedGoogle Scholar
- Haghi D, Fluechter S, Suselbeck T, Kaden JJ, Borggrefe M, Papavassiliu T: Cardiovascular magnetic resonance findings in typical versus atypical forms of the acute apical ballooning syndrome (Takotsubo cardiomyopathy). Int J Cardiol. 2007, 120: 205-211. 10.1016/j.ijcard.2006.09.019.View ArticlePubMedGoogle Scholar
- Balaguer JR, Estornell J, Planas AM, Jacas V, Nadal M: Transient left ventricular apical ballooning and cardiac magnetic resonance. Int J Cardiol. 2006, 108: 262-263. 10.1016/j.ijcard.2005.02.055.View ArticlePubMedGoogle Scholar
- Bruder O, Hunold P, Jochims M, Waltering KU, Sabin GV, Barkhausen J: Reversible late gadolinium enhancement in a case of takotsubo cardiomyopathy following high-dose dobutamine stress MRI. Int J Cardiol. 2008, 127: e22-e24. 10.1016/j.ijcard.2007.01.081.View ArticlePubMedGoogle Scholar
- Avegliano G, Huguet M, Costabel JP, Ronderos R, Bijnens B, Kuschnir P, Thierer J, Tobón-Gomez C, Martinez GO, Frangi A: Morphologic pattern of late gadolinium enhancement in takotsubo cardiomyopathy detected by early cardiovascular magnetic resonance. Clin Cardiol. 2011, 34: 178-182. 10.1002/clc.20877.View ArticlePubMedGoogle Scholar
- Rolf A, Nef HM, Möllmann H, Troidl C, Voss S, Conradi G, Rixe J, Steiger H, Beiring K, Hamm CW, Dill T: Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. Eur Heart J. 2009, 30: 1635-1642. 10.1093/eurheartj/ehp140.View ArticlePubMedGoogle Scholar
- Eitel I, von Knobelsdorff-Brenkenhoff F, Bernhardt P, Carbone I, Muellerleile K, Aldrovandi A, Francone M, Desch S, Gutberlet M, Strohm O, Schuler G, Schulz-Menger J, Thiele H, Friedrich MG: Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA. 2011, 306: 277-286. 10.1001/jama.2011.992.PubMedGoogle Scholar
- Prasad A, Lerman A, Rihal CS: Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008, 155: 408-417. 10.1016/j.ahj.2007.11.008.View ArticlePubMedGoogle Scholar
- Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA: Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation. 2002, 106: 1083-1089. 10.1161/01.CIR.0000027818.15792.1E.View ArticlePubMedGoogle Scholar
- Reynolds HR, Hochman JS: Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008, 117: 686-697. 10.1161/CIRCULATIONAHA.106.613596.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.